SUBSCRIBE
SUBSCRIBE

Gilead Sciences, Inc.

NEWS
Gilead's $12B Bet Pays Off in Two Months After the
Drug Development
Gilead Shows Off Mid-Stage NASH Data
Gilead released results from a Phase II clinical trial of GS-0976 for NASH.
October 24, 2017
 · 
2 min read
 · 
Mark Terry
Gemini Therapeutics Banks $42.5M to Bring Precisio
BioMidwest
These 3 Gene Therapy Biotechs Could Make Investors Rich
Immuno-oncology and gene therapy has been a hot field for the last few years, and the approval of the first CAR-T therapies has only set the kindling ablaze.
October 23, 2017
 · 
3 min read
 · 
Mark Terry
Gilead's $12B Bet Pays Off in Two Months After the
FDA
Gilead’s $12B Bet Pays Off in Two Months After the FDA Approves Kite’s Revolutionary CAR-T Therapy
Maybe timing is everything. On Aug. 28, 2017, Gilead acquired Kite for about $11.9B.
October 18, 2017
 · 
3 min read
 · 
Mark Terry
Biotech Bay
Are Analysts Secretly Calling Gilead A Screaming Buy?
October 13, 2017
 · 
1 min read
Harmony Biosciences Gains U.S. Rights to Pitolisant, Raises $270 Million
Business
How Much Cash Kite Pharma’s Execs Made From Its $12 Billion Gilead Deal
September 29, 2017
 · 
2 min read
Why Booming Vertex is on Its Way to Becoming Gilead's Mini-Me
Biotech Bay
Why Booming Vertex is on Its Way to Becoming Gilead’s Mini-Me
September 28, 2017
 · 
3 min read
Big Pharma Edgy After Revival of Gilead's Whistleblower Lawsuit
Policy
Big Pharma Edgy After Revival of Gilead’s Whistleblower Lawsuit
September 27, 2017
 · 
2 min read
Big Pharma Edgy After Revival of Gilead's Whistleblower Lawsuit
Deals
How Gilead’s $12 Billion Kite Pharma Deal Has Already Paid Off for Investors
September 19, 2017
 · 
2 min read
Deals
5 Tough Questions For Gilead About The Kite Pharma Acquisition
September 12, 2017
 · 
1 min read
Load More
  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Business
Gilead Sciences Announces Leadership Changes in Corporate Development and Strategy
June 4, 2018
 · 
3 min read
Drug Development
Kite Announces Initial Results From a Phase 1 Study of T Cell Receptor (TCR) Cell Therapy in HPV-16-Positive Solid Tumors
June 4, 2018
 · 
5 min read
Drug Development
Kite Announces New Data Analyses for CAR T Therapy in Patients with Blood Cancers at the 2018 American Society of Clinical Oncology Meeting
June 4, 2018
 · 
14 min read
Biotech Bay
Gilead Sciences to Present at the Goldman Sachs 39th Annual Global Healthcare Conference on Wednesday, June 13
May 30, 2018
 · 
1 min read
Drug Development
Gilead and Galapagos Announce Results With Filgotinib in the Phase 2 Equator Study in Psoriatic Arthritis and Progression Into Phase 3 for the Selection Study in Ulcerative Colitis
May 30, 2018
 · 
10 min read
Drug Development
China Drug Administration Approves Epclusa® (Sofosbuvir/Velpatasvir), Gilead’s Pan-Genotypic Treatment for Chronic Hepatitis C Virus Infection
May 30, 2018
 · 
7 min read
Biotech Bay
U.S. Food and Drug Administration Approves Expanded Indication for Truvada® (Emtricitabine and Tenofovir Disoproxil Fumarate) for Reducing the Risk of Acquiring HIV-1 in Adolescents
May 15, 2018
 · 
11 min read
Policy
Gilead Lawsuits: California HIV Patients File Class Action and Personal Injury Cases Over Key HIV Drug
May 9, 2018
 · 
8 min read
Biotech Bay
Gilead Sciences to Present at the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 16
May 8, 2018
 · 
1 min read
Business
Gilead Sciences Announces First Quarter 2018 Financial Results
May 1, 2018
 · 
23 min read
Load More